±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 4629  |  »Ø¸´: 69
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û60´Î£¬×÷Õßzhuimengren639Ôö¼Ó½ð±Ò 56.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

[×ÊÔ´] ·ÖÏí£ºµÂ¹úº£µÂ±¤´óѧHugo Kubinyi½ÌÊÚµÄÒ©ÎïÉè¼ÆµÄ¿Î¼þ

µÂ¹úUniversity of HeidelbergµÄÖøÃûÒ©Îﻯѧ¼ÒHugo Kubinyi¹ØÓÚÒ©ÎïÉè¼ÆµÄ¿Î¼þ£¬ÏàÐŶԸãÒ©ÎïÉè¼ÆµÄͬѧ»áÓÐÓõġ£

Èç¹û¸Ð¾õµ¥¸öÏÂÔØÌ«Âé·³£¬ÄÇô¿ÉÒÔÓà flashget/ѸÀ×ÅúÁ¿ÏÂÔØ£¬Ï£Íû´ó¼ÒÄܹ»Ï²»¶£¬Ó»Ô¾ÆÀÂÛ£¡

¿´µ½ÓÐÕâô¶à³æÓÑϲ»¶Õâ¸ö¿Î¼þ£¬ÎªÁ˸Ðл´ó¼Ò£¬ÎÒ°ÑÎÒÏÂÔØµÄ´«µ½ÄÉÃ×ÅÌÉϹ©´ó¼ÒÏÂÔØ£¬µØÖ·ÈçÏÂ
http://www.namipan.com/d/Hugo%20 ... c4504bad9361a9db300


ÄÚÈÝ:

Drug Discovery (758 kBlack Eye
http://www.kubinyi.de/dd-01.pdf

Serendipity and Rational Design (374 kBlack Eye
http://www.kubinyi.de/dd-02.pdf

Chemogenomics (1,453 kBlack Eye
http://www.kubinyi.de/dd-03.pdf

Ligand-Receptor Interactions (647 kBlack Eye
http://www.kubinyi.de/dd-04.pdf

Hydrogen Bonds and Biological Activities (359 kBlack Eye
http://www.kubinyi.de/dd-05.pdf

Chemical Similarity and Biological Activities (686 kBlack Eye
http://www.kubinyi.de/dd-06.pdf

Drug Metabolism (501 kBlack Eye
http://www.kubinyi.de/dd-07.pdf

Peptidomimetics and Prodrugs (294 kBlack Eye
http://www.kubinyi.de/dd-08.pdf

Combinatorial Chemistry Technology (147 kBlack Eye
http://www.kubinyi.de/dd-09.pdf

Combinatorial Chemistry in Drug Research (215 kBlack Eye
http://www.kubinyi.de/dd-10.pdf

QSAR Parameters (284 kBlack Eye
http://www.kubinyi.de/dd-11.pdf

QSAR - Hansch and Free Wilson Analyses (153 kBlack Eye
http://www.kubinyi.de/dd-12.pdf

Variable Selection and Model Validation (935 kBlack Eye
http://www.kubinyi.de/dd-13.pdf

Nonlinear QSAR and 3D QSAR (173 kBlack Eye
http://www.kubinyi.de/dd-14.pdf

QSAR Examples (138 kBlack Eye
http://www.kubinyi.de/dd-15.pdf

Structure-Based Ligand Design (782 kBlack Eye
http://www.kubinyi.de/dd-16.pdf

Computer-Aided Ligand Design (850 kBlack Eye
http://www.kubinyi.de/dd-17.pdf

Pharmacophore Analyses (486 kBlack Eye
http://www.kubinyi.de/dd-18.pdf

Virtual Screening (299 kBlack Eye
http://www.kubinyi.de/dd-19.pdf

Combinatorial and Fragment-Based Ligand Design (945 kBlack Eye
http://www.kubinyi.de/dd-20.pdf

Serine Proteases and their Inhibitors (371 kBlack Eye
http://www.kubinyi.de/dd-21.pdf

Thrombin Inhibitor Design (332 kBlack Eye
http://www.kubinyi.de/dd-22.pdf

Problems in Drug Design (1,043 kBlack Eye
http://www.kubinyi.de/dd-23.pdf

In Search for New Leads
http://www.kubinyi.de/paris-07-05.pdf

From Leads to Drugs
http://www.kubinyi.de/wien-06-05.pdf

Validation and Predictivity of QSAR Models
http://www.kubinyi.de/istanbul-2004-lecture.pdf

[ Last edited by zhuimengren639 on 2008-10-25 at 22:39 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dujawell

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ºÃ¶«Î÷!!
ÐÒ¿àÁË£¬Ð»Ð»£¡£¡
27Â¥2008-10-26 11:07:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 70 ¸ö»Ø´ð

xufund

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

very good
thanks
2Â¥2008-10-24 21:09:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gp0713

Òø³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

very good£¡thanks£¡
3Â¥2008-10-24 21:59:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lijianyong

½ð³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ºÃµÄºÜ°¡
лл
ÓйØÒ©ÎïÉè¼Æ¶¼»¶Ó­
5Â¥2008-10-25 03:15:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
2008-10-24 22:03   »Ø¸´  
 
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Àíѧ07»¯Ñ§ 303Çóµ÷¼Á +4 î£08 2026-03-27 4/200 2026-03-30 23:29 by yujianx
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì 317Çóµ÷¼Á +7 JKSOIID 2026-03-26 7/350 2026-03-30 20:10 by µÎµÎÉϰ¶Ñ½
[¿¼ÑÐ] 328Çóµ÷¼Á +8 àŵεĻù±¾¶¼ 2026-03-27 8/400 2026-03-30 17:20 by Wang200018
[¿¼ÑÐ] 310Çóµ÷¼Á +10 ÕùÈ¡¾Åµã˯ 2026-03-30 10/500 2026-03-30 16:45 by ztnimte
[¿¼ÑÐ] ±¾¿Æ211ÉúÎïҽѧ¹¤³Ì085409Çóµ÷¼Á339·Ö +3 Àï×Óľyy 2026-03-29 3/150 2026-03-30 13:29 by gyzj2026
[¿¼ÑÐ] 0703»¯Ñ§ +14 ÄÝÄÝninicgb 2026-03-27 14/700 2026-03-30 12:46 by fangnagu
[˶²©¼ÒÔ°] Çóµ÷¼Á Óлú»¯Ñ§¿¼ÑÐ356·Ö +10 Nadiums 2026-03-25 11/550 2026-03-30 11:56 by yjolah
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +4 Çñgl 2026-03-26 7/350 2026-03-30 08:39 by ̽123
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©µ÷¼Á +5 Feisty¡£ 2026-03-28 9/450 2026-03-29 12:02 by longlotian
[¿¼ÑÐ] ÊýÒ»Ó¢Ò»271ר˶£¨085401£©Çóµ÷¼Á£¬¿É¿ç +7 ǰÐбØÓйâ 2026-03-28 8/400 2026-03-28 23:22 by Сľ³ætim
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +9 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 10/500 2026-03-28 22:17 by chemzp
[¿¼ÑÐ] 071000ÉúÎïѧÇóµ÷¼Á£¬³õÊԳɼ¨343 +7 ССÌðÃæÍÅ 2026-03-25 7/350 2026-03-28 20:25 by ÌÆãå¶ù
[¿¼ÑÐ] 085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á +12 ·³ÕСç÷ 2026-03-27 12/600 2026-03-28 15:41 by L135790
[¿¼ÑÐ] 265Çóµ÷¼Á11408 +3 ÁõС¹lu 2026-03-27 3/150 2026-03-27 20:53 by nihaoar
[¿¼ÑÐ] 266Çóµ÷¼Á +11 ÑôÑôÍÛÈû 2026-03-27 12/600 2026-03-27 17:56 by yu221
[¿¼ÑÐ] 324Çóµ÷¼Á +5 hanamiko 2026-03-26 5/250 2026-03-27 10:33 by wangjy2002
[¿¼ÑÐ] 286Çóµ÷¼Á +4 lim0922 2026-03-26 4/200 2026-03-27 10:28 by guoweigw
[¿¼ÑÐ] 285Çóµ÷¼Á +3 AZMK 2026-03-24 3/150 2026-03-25 12:23 by userper
[¿¼ÑÐ] 085404µç×ÓÐÅÏ¢284·ÖÇóµ÷¼Á +4 13659058978 2026-03-24 4/200 2026-03-24 12:15 by syl20081243
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û